Henry Schein 2009 Annual Report Download - page 24

12
While we believe that we are substantially compliant with the foregoing laws and regulations
promulgated thereunder and possess all material permits and licenses required for the conduct of our business,
there can be no assurance that regulations that impact our business or customers’ practices will not have a
material adverse impact on our business. As a result of political, economic and regulatory influences, the
healthcare distribution industry in the United States is under intense scrutiny and subject to fundamental
changes. We cannot predict what reform proposals, if any, will be adopted, when they may be adopted, or
what impact they may have on us.
See “ITEM 1A. Risk Factors” for a discussion of additional regulatory developments that may affect our
results of operations and financial condition.
Proprietary Rights
We hold trademarks relating to the “Henry Schein” name and logo, as well as certain other trademarks.
Pursuant to agreements executed in connection with our reorganization in 1994, both Henry Schein, Inc. and
Schein Pharmaceutical, Inc. (which was acquired by Watson Pharmaceuticals, Inc. in 2000), a company
previously engaged in the manufacture and distribution of multi-source pharmaceutical products, are entitled
to use the “Schein” name in connection with their respective businesses, but Schein Pharmaceutical, Inc. must
always use “Schein” in combination with the word “Pharmaceutical” and is not entitled to use the name
“Henry Schein” or to use “Schein” alone or with any other word (other than “Pharmaceutical”). We intend to
protect our trademarks to the fullest extent practicable.
Employees
As of December 26, 2009, we employed more than 12,500 full-time employees, including approximately
1,400 telesales representatives, 2,750 field sales consultants, including equipment sales specialists, 2,250
warehouse employees, 500 computer programmers and technicians, 1,150 management employees and 4,800
office, clerical and administrative employees. Approximately 279 or 2.2% of our employees were subject to
collective bargaining agreements. We believe that our relations with our employees are excellent.
Available Information
We make available free of charge through our Internet Web site, www.henryschein.com, our annual
report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, statements of beneficial
ownership of securities on Forms 3, 4 and 5 and amendments to these reports and statements filed or
furnished pursuant to Section 13(a) and Section 16 of the Securities Exchange Act of 1934 as soon as
reasonably practicable after such materials are electronically filed with, or furnished to, the SEC.
The above information is also available at the SEC’s Office of Investor Education and Advocacy at
United States Securities and Exchange Commission, 100 F Street, N.E., Washington, D.C. 20549-0213 or
obtainable by calling the SEC at [phone]. In addition, the SEC maintains an Internet Web site at
www.sec.gov, where the above information can be viewed.
Our principal executive offices are located at 135 Duryea Road, Melville, New York 11747, and our
telephone number is [phone]. Unless the context specifically requires otherwise, the terms the
“Company,” “Henry Schein,” “we,” “us” and “our” mean Henry Schein, Inc., a Delaware corporation, and its
consolidated subsidiaries.